Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2024.100647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Luca Sigalotti und 25 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, I…. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, Sarcoma, Biomarkers, Tumor, SOXF Transcription Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Alleanza Contro il Cancro, Ministero della Salute.
Abstract (Originalsprache)
Epithelioid sarcoma (ES) is a rare tumor hallmarked by the loss of INI1/SMARCB1 expression. Apart from this alteration, little is known about the biology of ES. Despite recent advances in treatment, the prognosis of ES remains unsatisfactory. To elucidate the molecular underpinnings of ES, and to identify diagnostic biomarkers and potential therapeutic vulnerabilities, we performed an integrated omics profiling (RNA sequencing and methylation array) of 24 primary, untreated ESs. Transcriptome and methylome analysis identified 2 distinct molecular clusters that essentially corresponded to the morphologic variants of ES, classic ES (C-ES) and the more aggressive proximal ES (P-ES). The P-ES group was characterized by hyperactivation of GATA3 and MYC pathways, with extensive epigenetic rewiring associated with EZH2 overexpression. Both DNA methylation and gene expression analysis indicated a striking similarity with the "MYC subgroup" of atypical teratoid/rhabdoid tumor, another SMARCB1-deficient tumor, implying a shared molecular background and potential therapeutic vulnerabilities. Conversely, the C-ES group exhibited an endothelial-like molecular profile, with expression of vascular genes and elevated proangiogenic SOX17 signaling. Immunohistochemistry validated the overexpression of the chromatin regulators GATA3 (9/12 vs 0/16) and EZH2 (7/7 vs 2/6) in P-ESs, and of the vascular factors SOX17 (8/8 vs 1/10) and N-cadherin (5/9 vs 0/10) in C-ESs. Therefore, these molecules emerge as potential diagnostic tools to fill the gap represented by the lack of ES subtype-specific biomarkers. In summary, our study shows that P-ES and C-ES represent distinct molecular entities defined by MYC/GATA3 and SOX17/endothelial molecular traits, respectively. Besides providing insights into the biology of ES, our study pinpoints subtype-specific biomarkers and potential therapeutic vulnerabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy.
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, Padua, Italy.
- Department of Pathology, Azienda Ospedale Università Padova, Padua, Italy.
- Department of Pathology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.
- Department of Medical Oncology, Università Campus Biomedico di Roma, Rome, Italy.
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Alleanza Contro il Cancro
- Ministero della Salute
Zitieren
APA
Sigalotti, L., Frezza, A. M., Sbaraglia, M., Del Savio, E., Baldazzi, D., Valenti, B., Bellan, E., De Benedictis, I., Doni, M., Gambarotti, M., Vincenzi, B., Brunello, A., Baldi, G. G., Palmerini, E., Pasquali, S., Ciuffetti, M. E., Varano, V., Cappello, F., Appolloni, V., …, & Maestro, R. (2025). Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100647
Vancouver
Sigalotti L, Frezza AM, Sbaraglia M, Del Savio E, Baldazzi D, Valenti B, et al. Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively. Modern Pathology. 2025. doi:10.1016/j.modpat.2024.100647
BibTeX
@article{Sigalotti2025,
author = {Sigalotti, Luca and Frezza, Anna Maria and Sbaraglia, Marta and Del Savio, Elisa and Baldazzi, Davide and Valenti, Beatrice and Bellan, Elena and De Benedictis, Ilaria and Doni, Michele and Gambarotti, Marco and Vincenzi, Bruno and Brunello, Antonella and Baldi, Giacomo Giulio and Palmerini, Emanuela and Pasquali, Sandro and Ciuffetti, Maria Elena and Varano, Veronica and Cappello, Filippo and Appolloni, Viviana and Pastrello, Chiara and Jurisica, Igor and Gronchi, Alessandro and Stacchiotti, Silvia and Casali, Paolo Giovanni and Dei Tos, Angelo Paolo and Maestro, Roberta},
title = {Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2024.100647}
}
EUVIMED